{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:21Z","timestamp":1790632581360,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research Grant","doi-asserted-by":"crossref","award":["# ECD-144626"],"award-info":[{"award-number":["# ECD-144626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Institutes of Health Research Grant operating grant","award":["CIHR-450137"],"award-info":[{"award-number":["CIHR-450137"]}]},{"name":"Canadian Institutes of Health Research Grant operating grant","award":["CIHR-450137"],"award-info":[{"award-number":["CIHR-450137"]}]},{"name":"Canadian Institutes of Health Research Grant operating grant","award":["CIHR-450137"],"award-info":[{"award-number":["CIHR-450137"]}]},{"name":"Canadian Institutes of Health Research Grant operating grant","award":["CIHR-450137"],"award-info":[{"award-number":["CIHR-450137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanisms of NASH development in the context of age and genetics are not fully elucidated. This study investigates the age-dependent liver defects during NASH development in mice with heterozygous deletion of Pcyt2 (<jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup>)<jats:italic>,<\/jats:italic> the rate limiting enzyme in phosphatidylethanolamine (PE) synthesis. Further, the therapeutic potential of the artificial Pcyt2 substrate, phosphonoethylamine (PEA), is examined. <jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup> were investigated at 2 and 6\u20138\u00a0months (mo) of age and in addition, 6-mo old <jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup> with developed NASH were supplemented with PEA for 8\u00a0weeks and glucose and fatty acid metabolism, insulin signaling, and inflammation were examined. Heterozygous ablation of Pcyt2 causes changes in liver metabolic regulators from young age, prior to the development of liver disease which does not occur until adulthood. Only older <jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup> experiences perturbed glucose and fatty acid metabolism. Older <jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup> liver develops NASH characterized by increased glucose production, accumulation of TAG and glycogen, and increased inflammation. Supplementation with PEA reverses <jats:italic>Pcyt2<\/jats:italic><jats:sup>+<jats:italic>\/\u2212<\/jats:italic><\/jats:sup> steatosis, inflammation, and other aspects of NASH, showing that was directly caused by <jats:italic>Pcyt2<\/jats:italic> deficiency. Pcyt2 deficiency is a novel mechanism of metabolic dysregulation due to reduced membrane ethanolamine phospholipid synthesis, and the artificial Pcyt2 substrate PEA offers therapeutic potential for NASH reversion.<\/jats:p>","DOI":"10.1038\/s41598-022-05140-y","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T11:05:12Z","timestamp":1642676712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphonoethylamine"],"prefix":"10.1038","volume":"12","author":[{"given":"Sophie","family":"Grapentine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathnesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poulami","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugashan","family":"Sivanesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreoluwa","family":"Oresajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendwesen","family":"Demeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon W.","family":"Dolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Bakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"5140_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"5140_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123\u2013133 (2018).","journal-title":"Hepatology"},{"key":"5140_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/ijms14022529","volume":"14","author":"Z Pavlovic","year":"2013","unstructured":"Pavlovic, Z. & Bakovic, M. Regulation of phosphatidylethanolamine homeostasis\u2014the critical role of CTP: phosphoethanolamine cytidylyltransferase (Pcyt2). Int J Mol Sci 14, 2529\u20132550 (2013).","journal-title":"Int J Mol Sci"},{"key":"5140_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/iub.354","volume":"62","author":"F Gibellini","year":"2010","unstructured":"Gibellini, F. & Smith, T. K. The Kennedy pathway\u2013De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414\u2013428 (2010).","journal-title":"IUBMB Life"},{"key":"5140_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/0006-291X(92)91862-K","volume":"182","author":"LB Tijburg","year":"1992","unstructured":"Tijburg, L. B., Vermeulen, P. S., Schmitz, M. G. & van Golde, L. M. Okadaic acid inhibits phosphatidylethanolamine biosynthesis in rat hepatocytes. Biochem. Biophys. Res. Commun. 182, 1226\u20131231 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5140_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.gene.2014.04.005","volume":"543","author":"Z Pavlovic","year":"2014","unstructured":"Pavlovic, Z., Singh, R. K. & Bakovic, M. A novel murine CTP:phosphoethanolamine cytidylyltransferase splice variant is a post-translational repressor and an indicator that both cytidylyltransferase domains are required for activity. Gene 543, 58\u201368 (2014).","journal-title":"Gene"},{"key":"5140_CR7","doi-asserted-by":"crossref","unstructured":"Zhu, L. & Bakovic, M. Liver X receptor agonists inhibit the phospholipid regulatory gene CTP: phosphoethanolamine cytidylyltransferase-Pcyt2. Res. Lett. Biochem. vol. 2008 e801849 https:\/\/www.hindawi.com\/journals\/bri\/2008\/801849\/ (2008).","DOI":"10.1155\/2008\/801849"},{"key":"5140_CR8","doi-asserted-by":"publisher","first-page":"9053","DOI":"10.1074\/jbc.M113.544932","volume":"289","author":"Z Pavlovic","year":"2014","unstructured":"Pavlovic, Z. et al. Isoform-specific and protein kinase C-mediated regulation of CTP:phosphoethanolamine cytidylyltransferase phosphorylation. J. Biol. Chem. 289, 9053\u20139064 (2014).","journal-title":"J. Biol. Chem."},{"key":"5140_CR9","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1096\/fj.201802117R","volume":"33","author":"JN van der Veen","year":"2019","unstructured":"van der Veen, J. N. et al. A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling. FASEB J. 33, 5045\u20135057 (2019).","journal-title":"FASEB J."},{"key":"5140_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13148-018-0490-3","volume":"10","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y. et al. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity: a pilot study. Clin Epigenet 10, 54 (2018).","journal-title":"Clin Epigenet"},{"key":"5140_CR11","doi-asserted-by":"crossref","unstructured":"Sharma, N. K., Langberg, K. A., Mondal, A. K. & Das, S. K. Phospholipid biosynthesis genes and susceptibility to obesity: analysis of expression and polymorphisms. PLoS One 8, (2013).","DOI":"10.1371\/annotation\/7b3edc45-39c7-416b-a7dc-124f4846303d"},{"key":"5140_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.abb.2018.03.003","volume":"644","author":"JP ten Klooster","year":"2018","unstructured":"ten Klooster, J. P. et al. Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue. Arch. Biochem. Biophys. 644, 81\u201392 (2018).","journal-title":"Arch. Biochem. Biophys."},{"key":"5140_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.metabol.2010.03.022","volume":"59","author":"MD Fullerton","year":"2010","unstructured":"Fullerton, M. D. & Bakovic, M. Complementation of the metabolic defect in CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)\u2013deficient primary hepatocytes. Metabolism 59, 1691\u20131700 (2010).","journal-title":"Metabolism"},{"key":"5140_CR14","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/brain\/awz291","volume":"142","author":"FM Vaz","year":"2019","unstructured":"Vaz, F. M. et al. Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia. Brain 142, 3382\u20133397 (2019).","journal-title":"Brain"},{"key":"5140_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa442","author":"R Kaiyrzhanov","year":"2021","unstructured":"Kaiyrzhanov, R. et al. Defective phosphatidylethanolamine biosynthesis leads to a broad ataxia-spasticity spectrum. Brain https:\/\/doi.org\/10.1093\/brain\/awaa442 (2021).","journal-title":"Brain"},{"key":"5140_CR16","unstructured":"pcyt2 - SNP-NCBI. https:\/\/www.ncbi.nlm.nih.gov\/snp\/?term=pcyt2."},{"key":"5140_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00232-007-9086-0","volume":"221","author":"HR Modi","year":"2008","unstructured":"Modi, H. R., Katyare, S. S. & Patel, M. A. Ageing-induced alterations in lipid\/phospholipid profiles of rat brain and liver mitochondria: implications for mitochondrial energy-linked functions. J. Membr. Biol. 221, 51\u201360 (2008).","journal-title":"J. Membr. Biol."},{"key":"5140_CR18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.18632\/aging.101204","volume":"9","author":"AK Pollard","year":"2017","unstructured":"Pollard, A. K., Ortori, C. A., St\u00f6ger, R., Barrett, D. A. & Chakrabarti, L. Mouse mitochondrial lipid composition is defined by age in brain and muscle. Aging (Albany NY) 9, 986\u2013995 (2017).","journal-title":"Aging (Albany NY)"},{"key":"5140_CR19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo, P., Keach, J. C., Batts, K. P. & Lindor, K. D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356\u20131362 (1999).","journal-title":"Hepatology"},{"key":"5140_CR20","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1128\/MCB.01527-06","volume":"27","author":"MD Fullerton","year":"2007","unstructured":"Fullerton, M. D., Hakimuddin, F. & Bakovic, M. Developmental and metabolic effects of disruption of the mouse CTP: phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol. Cell. Biol. 27, 3327 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"5140_CR21","doi-asserted-by":"publisher","first-page":"25704","DOI":"10.1074\/jbc.M109.023846","volume":"284","author":"MD Fullerton","year":"2009","unstructured":"Fullerton, M. D., Hakimuddin, F., Bonen, A. & Bakovic, M. The development of a metabolic disease phenotype in CTP: phosphoethanolamine cytidylyltransferase-deficient mice. J. Biol. Chem. 284, 25704\u201325713 (2009).","journal-title":"J. Biol. Chem."},{"key":"5140_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbrc.2020.03.180","volume":"527","author":"Y Arao","year":"2020","unstructured":"Arao, Y. et al. Effect of methionine\/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice. Biochem. Biophys. Res. Commun. 527, 365\u2013371 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5140_CR23","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","volume":"23","author":"CZ Larter","year":"2008","unstructured":"Larter, C. Z. & Yeh, M. M. Animal models of NASH: Getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23, 1635\u20131648 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"5140_CR24","doi-asserted-by":"crossref","unstructured":"Machado, M. V. et al. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLOS One 10, e0127991 (2015).","DOI":"10.1371\/journal.pone.0127991"},{"key":"5140_CR25","doi-asserted-by":"crossref","unstructured":"Curley-Joseph, J. & Henderson, T. O. 2-Aminoethylphosphonic acid metabolism in the rat. Lipids 12, 75\u201384 (1977).","DOI":"10.1007\/BF02532976"},{"key":"5140_CR26","doi-asserted-by":"crossref","unstructured":"Alhadeff, J. A. & Doyle Daves, G. 2-Aminoethylphosphonic acid: Distribution in human tissues. Biochimica et Biophysica Acta (BBA) - General Subjects 244, 211\u2013213 (1971).","DOI":"10.1016\/0304-4165(71)90139-5"},{"key":"5140_CR27","doi-asserted-by":"publisher","unstructured":"Kafarski, P. Phosphonates: Their Natural Occurrence and Physiological Role. in Contemporary Topics about Phosphorus in Biology and Materials (IntechOpen, 2019). https:\/\/doi.org\/10.5772\/intechopen.87155.","DOI":"10.5772\/intechopen.87155"},{"key":"5140_CR28","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0022-2275(20)38756-3","volume":"27","author":"MA Yorek","year":"1986","unstructured":"Yorek, M. A., Dunlap, J. A., Spector, A. A. & Ginsberg, B. H. Effect of ethanolamine on choline uptake and incorporation into phosphatidylcholine in human Y79 retinoblastoma cells. J Lipid Res 27, 1205\u20131213 (1986).","journal-title":"J Lipid Res"},{"key":"5140_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jnutbio.2015.05.014","volume":"26","author":"LC Schenkel","year":"2015","unstructured":"Schenkel, L. C. et al. Choline supplementation restores substrate balance and alleviates complications of Pcyt2 deficiency. J. Nutr. Biochem. 26, 1221\u20131234 (2015).","journal-title":"J. Nutr. Biochem."},{"key":"5140_CR30","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1096\/fj.08-121491","volume":"23","author":"V Michel","year":"2009","unstructured":"Michel, V. & Bakovic, M. The solute carrier 44A1 is a mitochondrial protein and mediates choline transport. FASEB J 23, 2749\u20132758 (2009).","journal-title":"FASEB J"},{"key":"5140_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1021\/bi00909a014","volume":"1","author":"DL Dipietro","year":"1962","unstructured":"Dipietro, D. L., Sharma, C. & Weinhouse, S. Studies on glucose phosphorylation in rat liver*. Biochemistry 1, 455\u2013462 (1962).","journal-title":"Biochemistry"},{"key":"5140_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1152\/jappl.1970.28.2.234","volume":"28","author":"S Lo","year":"1970","unstructured":"Lo, S., Russell, J. C. & Taylor, A. W. Determination of glycogen in small tissue samples. J Appl Physiol 28, 234\u2013236 (1970).","journal-title":"J Appl Physiol"},{"key":"5140_CR33","doi-asserted-by":"crossref","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr Protocols 1, e90 (2021).","DOI":"10.1002\/cpz1.90"},{"key":"5140_CR34","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90-97 (2016).","journal-title":"Nucleic Acids Res"},{"key":"5140_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"5140_CR36","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/hmg\/4.8.1313","volume":"4","author":"L Hansen","year":"1995","unstructured":"Hansen, L. et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum. Mol. Genet. 4, 1313\u20131320 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"5140_CR37","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1194\/jlr.M021881","volume":"53","author":"RK Singh","year":"2012","unstructured":"Singh, R. K., Fullerton, M. D., Vine, D. & Bakovic, M. Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J Lipid Res 53, 1811\u20131822 (2012).","journal-title":"J Lipid Res"},{"key":"5140_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res"},{"key":"5140_CR39","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci 28, 1947\u20131951 (2019).","journal-title":"Protein Sci"},{"key":"5140_CR40","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49, D545\u2013D551 (2021).","journal-title":"Nucleic Acids Res"},{"key":"5140_CR41","doi-asserted-by":"crossref","unstructured":"Taylor, A., Grapentine, S., Ichhpuniani, J. & Bakovic, M. Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters. J. Biol. Chem. 296, (2021).","DOI":"10.1016\/j.jbc.2021.100604"},{"key":"5140_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto, E., Taniai, M. & Tokushige, K. Characteristics and diagnosis of NAFLD\/NASH. J. Gastroenterol. Hepatol. 28, 64\u201370 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"5140_CR43","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt, D. S. & Kaplan, M. M. Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients. N. Engl. J. Med. 342, 1266\u20131271 (2000).","journal-title":"N. Engl. J. Med."},{"key":"5140_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali, G. et al. Human serum albumin: from bench to bedside. Mol. Aspects Med. 33, 209\u2013290 (2012).","journal-title":"Mol. Aspects Med."},{"key":"5140_CR45","doi-asserted-by":"crossref","unstructured":"Sivanesan, S., Taylor, A., Zhang, J. & Bakovic, M. Betaine and choline improve lipid homeostasis in obesity by participation in mitochondrial oxidative demethylation. Front. Nutr. 5, (2018).","DOI":"10.3389\/fnut.2018.00061"},{"key":"5140_CR46","doi-asserted-by":"publisher","first-page":"30409","DOI":"10.1074\/jbc.R200006200","volume":"277","author":"OE Owen","year":"2002","unstructured":"Owen, O. E., Kalhan, S. C. & Hanson, R. W. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277, 30409\u201330412 (2002).","journal-title":"J. Biol. Chem."},{"key":"5140_CR47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1194\/jlr.M023382","volume":"53","author":"S Satapati","year":"2012","unstructured":"Satapati, S. et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 53, 1080\u20131092 (2012).","journal-title":"J. Lipid Res."},{"key":"5140_CR48","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804\u2013810 (2011).","journal-title":"Cell Metab."},{"key":"5140_CR49","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2337\/db07-1769","volume":"57","author":"C Schmitz-Peiffer","year":"2008","unstructured":"Schmitz-Peiffer, C. & Biden, T. J. Protein Kinase C Function in Muscle, Liver, and \u03b2-Cells and Its Therapeutic Implications for Type 2 Diabetes. Diabetes 57, 1774\u20131783 (2008).","journal-title":"Diabetes"},{"key":"5140_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1128\/MCB.00380-15","volume":"35","author":"P Basu","year":"2015","unstructured":"Basu, P. et al. Male-specific cardiac dysfunction in CTP: phosphoethanolamine cytidylyltransferase (Pcyt2)-deficient mice. Mol Cell Biol 35, 2641\u20132657 (2015).","journal-title":"Mol Cell Biol"},{"key":"5140_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.livres.2017.11.004","volume":"1","author":"XC Dong","year":"2017","unstructured":"Dong, X. C. FOXO transcription factors in non-alcoholic fatty liver disease. Liver Res 1, 168\u2013173 (2017).","journal-title":"Liver Res"},{"key":"5140_CR52","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/me.2008-0264","volume":"23","author":"P Ramadoss","year":"2009","unstructured":"Ramadoss, P., Unger-Smith, N. E., Lam, F. S. & Hollenberg, A. N. STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol. Endocrinol. 23, 827\u2013837 (2009).","journal-title":"Mol. Endocrinol."},{"key":"5140_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","volume":"53","author":"L Yang","year":"2010","unstructured":"Yang, L. et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J. Hepatol. 53, 339\u2013347 (2010).","journal-title":"J. Hepatol."},{"key":"5140_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.24006","volume":"53","author":"KT Ong","year":"2011","unstructured":"Ong, K. T., Mashek, M. T., Bu, S. Y., Greenberg, A. S. & Mashek, D. G. ATGL is a major hepatic lipase that regulates TAG turnover and fatty acid signaling and partitioning. Hepatology 53, 116\u2013126 (2011).","journal-title":"Hepatology"},{"key":"5140_CR55","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1194\/jlr.M800614-JLR200","volume":"50","author":"JM Sapiro","year":"2009","unstructured":"Sapiro, J. M., Mashek, M. T., Greenberg, A. S. & Mashek, D. G. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity. J. Lipid Res. 50, 1621\u20131629 (2009).","journal-title":"J. Lipid Res."},{"key":"5140_CR56","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/1873-3468.13080","volume":"592","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Liu, Y., Huang, S. & Fang, M. TRAF6 interacts with and ubiquitinates PIK3CA to enhance PI3K activation. FEBS Lett. 592, 1882\u20131892 (2018).","journal-title":"FEBS Lett."},{"key":"5140_CR57","doi-asserted-by":"crossref","unstructured":"Torrealba, N. et al. TGF-\u03b2\/PI3K\/AKT\/mTOR\/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male 0, 1\u201311 (2019).","DOI":"10.1080\/13685538.2019.1597840"},{"key":"5140_CR58","doi-asserted-by":"publisher","first-page":"29322","DOI":"10.1074\/jbc.M502080200","volume":"280","author":"EA Waxman","year":"2005","unstructured":"Waxman, E. A. & Lynch, D. R. N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 Mitogen-activated Protein Kinase. J. Biol. Chem. 280, 29322\u201329333 (2005).","journal-title":"J. Biol. Chem."},{"key":"5140_CR59","doi-asserted-by":"publisher","first-page":"12908","DOI":"10.1073\/pnas.93.23.12908","volume":"93","author":"KG Mendelson","year":"1996","unstructured":"Mendelson, K. G., Contois, L.-R., Tevosian, S. G., Davis, R. J. & Paulson, K. E. Independent regulation of JNK\/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. PNAS 93, 12908\u201312913 (1996).","journal-title":"PNAS"},{"key":"5140_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12986-017-0202-6","volume":"14","author":"W-G Choi","year":"2017","unstructured":"Choi, W.-G. et al. eIF2\u03b1 phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. Nutr. Metab. 14, 48 (2017).","journal-title":"Nutr. Metab."},{"key":"5140_CR61","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7150\/ijbs.7.536","volume":"7","author":"H Wang","year":"2011","unstructured":"Wang, H., Lafdil, F., Kong, X. & Gao, B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int. J. Biol. Sci. 7, 536 (2011).","journal-title":"Int. J. Biol. Sci."},{"key":"5140_CR62","doi-asserted-by":"publisher","first-page":"G1044","DOI":"10.1152\/ajpgi.00184.2004","volume":"287","author":"B Jaruga","year":"2004","unstructured":"Jaruga, B., Hong, F., Kim, W.-H. & Gao, B. IFN-gamma\/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1044-1052 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"5140_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/br.2016.578","volume":"4","author":"Y-L Zhao","year":"2016","unstructured":"Zhao, Y.-L., Zhu, R.-T. & Sun, Y.-L. Epithelial-mesenchymal transition in liver fibrosis (Review). Biomed Rep 4, 269\u2013274 (2016).","journal-title":"Biomed Rep"},{"key":"5140_CR64","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Sci. Adv. 5, (2019).","DOI":"10.1126\/sciadv.aax7525"},{"key":"5140_CR65","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. Synthesis and anti-hepaticfibrosis of glycyrrhetinic acid derivatives with inhibiting COX-2. Bioorganic Chem. 99, 103804 (2020).","DOI":"10.1016\/j.bioorg.2020.103804"}],"updated-by":[{"DOI":"10.1038\/s41598-023-36725-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05140-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T23:07:49Z","timestamp":1687475269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05140-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5140"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05140-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-36725-w","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-36725-w","URL":"https:\/\/doi.org\/10.1038\/s41598-023-36725-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1048"}}